Research

World SBNR Resorts & Retreats

From cenotes in the Yucatan to ayahuasca lodges in the Amazon, from ibogaine clinics in Baja to cannabis retreats in Thailand — a map of the world's most transformative SBNR destinations and the substances, ceremonies, and legal realities that define them.

$12.1B

Global Wellness Tourism Market (Retreats)

GWI 2024

14.5%

Annual Growth Rate

Psychedelic-assisted therapy market CAGR

10,800

Reported Ayahuasca Users (50+ countries)

Global Drug Survey 2024

200+

Ayahuasca Retreat Centers in Peru Alone

Chacruna Institute estimate

The cenote does not come to you. You must descend.

— Maya proverb

Cave Retreats — Descending to Ascend

Caves have been humanity's first temples. From Paleolithic art in Lascaux (17,000 years ago) to the Ajanta meditation caves of India, the impulse to descend into darkness for transformation is universal. Today, cave-based retreats are experiencing a renaissance — combining the primal power of subterranean spaces with modern wellness practices.

Over 6,000 cenotes dot the Yucatan Peninsula — natural sinkholes that the ancient Maya considered portals to Xibalba, the underworld. Today, cenotes near Tulum and Valladolid host breath-work retreats, sound-healing ceremonies, and temazcal (sweat lodge) integration. Cenote Ik Kil, Cenote Dos Ojos, and the sacred cenote at Chichen Itza draw millions annually. The experience is visceral: descending into cool darkness, surrounded by ancient limestone, to float in crystalline water lit from above.

The fairy-chimney landscapes of Cappadocia contain thousands of cave dwellings carved by early Christians. Today, luxury cave hotels like Museum Hotel and Argos in Cappadocia offer meditation retreats within volcanic-rock chambers. The natural insulation, silence, and womb-like enclosure create an environment that many describe as profoundly grounding.

Son Doong — the world's largest cave — has become an extreme wellness destination. Multi-day expeditions through the cave system combine physical challenge with sensory deprivation and encounters with subterranean ecosystems. Nearby Phong Nha-Ke Bang hosts more accessible cave-based retreat programs.

These UNESCO World Heritage caves — carved between the 2nd century BCE and 10th century CE — were built as meditation chambers for Buddhist, Hindu, and Jain monks. Modern vipassana and yoga retreats in the surrounding Maharashtra region draw on this 2,200-year tradition of cave-based contemplative practice.

The vine does not teach. It reveals what was always there.

— Shipibo elder

Ayahuasca Retreats

Ayahuasca — a brew combining Banisteriopsis caapi vine and Psychotria viridis leaves — has been used by Amazonian peoples for at least 1,000 years. The active compound, DMT, produces intense visionary experiences lasting 4-6 hours. In the past two decades, ayahuasca tourism has exploded: the Global Drug Survey 2024 reported 10,800 users across 50+ countries, and Peru's Iquitos region alone hosts over 200 retreat centers.

The spectrum ranges from traditional multi-day Shipibo ceremonies with icaros (healing songs) to luxury jungle lodges charging $3,000-$10,000 per week, to microdosing programs that avoid the full visionary experience entirely. Some centers now offer integration therapy with licensed psychologists before and after ceremonies.

Ayahuasca Legal Status by Country

Country	Status	Notes
Peru	Legal	Declared national cultural heritage (2008). Over 200 retreat centers in Iquitos and Sacred Valley.
Brazil	Legal (religious)	Legal for religious use by Santo Daime, UDV, and Barquinha churches since 2006.
Costa Rica	Unregulated	No specific law prohibiting ayahuasca. Growing retreat industry in Guanacaste and Osa Peninsula.
Netherlands	Legal (analogue)	DMT is controlled but ayahuasca plant materials have been ruled legal by courts. Retreats operate openly in Amsterdam and countryside.
Portugal	Decriminalized	All drugs decriminalized for personal use since 2001. Ceremonial retreats operate in Alentejo and Algarve.
Japan	Illegal	DMT is Schedule I under the Narcotics and Psychotropics Control Act. Ayahuasca possession or use carries severe criminal penalties.

Japan: Strict Prohibition

In Japan, DMT — the active compound in ayahuasca — is classified as Schedule I under the Narcotics and Psychotropics Control Act. Possession, use, import, and distribution are criminal offenses carrying penalties of up to 7 years imprisonment. There is no religious exemption. Japanese nationals should be aware that participation in ayahuasca ceremonies abroad, while not prosecuted upon return, remains a legal gray area.

Iboga & Ibogaine

Ibogaine — the primary alkaloid of the African shrub Tabernanthe iboga — is perhaps the most medically promising and personally dangerous of all plant medicines. Research suggests a single ibogaine session can interrupt opioid withdrawal and reduce cravings for 3-6 months. Yet ibogaine also carries significant cardiac risks: QT interval prolongation can cause fatal arrhythmias.

50+

Ibogaine Clinics in Mexico

Baja California alone

30+

Reported Deaths (Clinical)

Cardiac risk: QT prolongation

3-6mo

Craving Reduction Duration

Post single ibogaine session

Iboga (Tabernanthe iboga) has been central to the Bwiti spiritual tradition for centuries. Initiation ceremonies involve consuming large doses of iboga root bark in multi-day rituals. The Gabonese government declared iboga a national treasure in 2000. However, growing Western demand for ibogaine — iboga's primary alkaloid — threatens wild plant populations.

Mexico has become the world's leading destination for ibogaine-assisted detox, with 50+ clinics operating in Baja California alone. Ibogaine is unregulated in Mexico, creating a boom in clinics treating opioid addiction. A single session can reportedly interrupt withdrawal symptoms and reduce cravings for months. However, ibogaine carries serious cardiac risks — at least 30 deaths have been reported globally in clinical settings.

New Zealand approved ibogaine for compassionate use in 2009, making it the first country to formally regulate ibogaine therapy. The MRINZ (Medical Research Institute of New Zealand) has conducted observational studies on ibogaine for opioid dependence. Results show sustained reductions in opioid use at 12-month follow-up.

Kambo — Amazonian Frog Medicine

Kambo is a secretion from the giant monkey frog (Phyllomedusa bicolor). Applied through small burns on the skin, it triggers intense purging — vomiting, sweating, facial swelling — lasting 20-40 minutes. Indigenous Matses and Mayoruna peoples have used it for centuries to sharpen hunting senses and build immunity. In the West, kambo ceremonies have spread rapidly through wellness circles in the UK, US, and Europe.

Kambo is not a controlled substance in most countries, but safety concerns are significant. At least 5 deaths have been linked to kambo ceremonies in the West. The peptides in kambo can cause acute cardiac events, hyponatremia (from excessive water intake during ceremonies), and anaphylaxis. No clinical trials have validated kambo's purported benefits.

Cannabis, THC & CBD — The Shifting Legal Landscape

Cannabis is the world's most widely used psychoactive substance after alcohol and tobacco. Its legal status is undergoing the most rapid transformation in drug policy history. As of 2024, recreational cannabis is fully legal in Canada, Uruguay, and 24 US states. Medical cannabis is legal in 50+ countries. Meanwhile, Japan passed its strictest-ever cannabis amendment in 2023, adding usage penalties for the first time.

Cannabis Legal Status

Region	Status	Notes
Canada	Fully Legal	Federal legalization since 2018 (Cannabis Act). Recreational and medical.
Uruguay	Fully Legal	First country to fully legalize (2013). State-controlled production and sale.
US (24 states)	State Legal	Recreational legal in 24 states + DC (as of 2024). Federally still Schedule I.
Netherlands	Tolerated	Gedoogbeleid (tolerance policy). Sale in coffeeshops tolerated, production technically illegal.
Thailand	Complex	Decriminalized in 2022. Cannabis cafes proliferated but re-regulation under debate.
Japan	Strictly Illegal	Cannabis Control Act: possession up to 5 years imprisonment. 2023 amendment added usage penalties for the first time.

The Microdosing Movement

Microdosing — taking sub-perceptual doses (typically 1/10th to 1/20th of a full dose) of psychedelics — has moved from Silicon Valley biohacking culture into mainstream wellness. A 2023 survey by the Beckley Foundation estimated that 5-10% of US adults have tried microdosing at least once. Common substances include psilocybin mushrooms (most popular), LSD, and ayahuasca vine extract.

The science is mixed. The largest placebo-controlled microdosing study to date (Imperial College London, 2021, n=191) found that while microdosers reported significant improvements in well-being and creativity, these effects were not distinguishable from placebo. Expectation, ritual, and intentionality may matter as much as — or more than — the substance itself. This finding paradoxically supports the SBNR thesis: the ceremony is the medicine.

5-10%

US Adults Who Have Tried

Beckley Foundation 2023

n=191

Largest Placebo-Controlled Study

Imperial College London 2021

Significant Difference vs Placebo

ICL study primary outcome

Other Shamanic Medicines

Beyond ayahuasca and iboga, a constellation of plant and animal medicines forms the broader landscape of shamanic pharmacology. Each carries its own cultural lineage, mechanism of action, and legal complexity.

Sacred cactus of the Huichol (Wixaritari) and Native American Church. Legal for NAC religious use in the US under AIRFA. Wirikuta pilgrimage in San Luis Potosi, Mexico is a UNESCO-pending cultural landscape. Peyote takes 10-15 years to mature; wild populations are threatened by land development and poaching.

Columnar cactus containing mescaline, used for 3,000+ years in Andean ceremony. Unlike peyote, San Pedro grows quickly and is cultivated legally in many countries as an ornamental plant. Ceremonies are held openly in Peru, Ecuador, and Bolivia. Effects last 8-14 hours and are often described as "gentler" than ayahuasca.

Secretion from the Sonoran Desert toad (Bufo alvarius) contains 5-MeO-DMT, one of the most potent psychedelics known. The experience lasts 15-30 minutes but is described as ego-dissolution of extraordinary intensity. Growing demand threatens wild toad populations — synthetic 5-MeO-DMT is increasingly advocated as a sustainable alternative. Legal status varies: unregulated in Mexico, controlled in most other countries.

Rape is a finely ground tobacco-based snuff blown into the nostrils via a pipe (tepi or kuripe). Used by Amazonian tribes for grounding, clearing sinuses, and ceremony preparation. Sananga is eye drops made from Tabernaemontana undulata root. Both are growing rapidly in Western wellness circles. While not controlled substances, both carry health risks if improperly administered.

Ethical Considerations

The SBNR retreat industry sits at the intersection of ancient wisdom and modern commerce — a tension that demands careful navigation.

Cultural Appropriation

When a $5,000/week ayahuasca lodge in Costa Rica employs Shipibo shamans at $50/day, who benefits from whose tradition? The Reciprocal Cacao Agreement (2023) and the Nagoya Protocol on genetic resources offer frameworks — but enforcement remains weak.

Sustainability

Wild iboga populations in Gabon are declining. Peyote takes 10-15 years to mature. Bufo alvarius toads face habitat pressure. The paradox: Western demand for these medicines threatens the ecosystems that produce them.

Safety

Unregulated retreat centers operate with no medical oversight. Serotonin syndrome from SSRI/ayahuasca interactions, cardiac events from ibogaine, and psychological crises from poorly supported psychedelic experiences are real risks. The 2009 Sedona sweat lodge deaths (3 killed, 18 hospitalized) remain a cautionary example.

Sources & Further Reading

Global Drug Survey (2024). Ayahuasca use across 50+ countries.
Chacruna Institute for Psychedelic Plant Medicines. Retreat center census, Peru.
Global Wellness Institute (2024). Global Wellness Economy Monitor.
Szigeti, B. et al. (2021). Self-blinding microdose study. eLife.
Noller, G. E. et al. (2018). Ibogaine treatment outcomes for opioid dependence. American Journal of Drug and Alcohol Abuse.
Labate, B. C. & Cavnar, C. (Eds.) (2014). Ayahuasca Shamanism in the Amazon and Beyond. Oxford University Press.
Nagoya Protocol on Access and Benefit-Sharing (2010). Convention on Biological Diversity.
Cannabis Control Act (Japan), 2023 Amendment.

← Back to Research